PURPOSE: Biallelic germ-line mutations in MUTYH have recently been found to predispose for MUTYH-associated polyposis (MAP). Affected patients present with a wide range of clinical phenotypes at the time of diagnosis, but there is little precise information about the natural course of this disease. RESULTS: Fourteen years of colonoscopic surveillance of an MAP patient (compound heterozygous p.Y165C/p.G382D) showed that adenoma development was slow after initial diagnosis of a single colorectal carcinoma at the age of 44, but then the annual number of new adenomas increased substantially in the patient's early fifties. CONCLUSION: This course of the disease, with a strong subsequent acceleration of polyp development, may explain the wide range of polyp numbers counted in newly diagnosed MAP patients as a result of the time of observation. Therefore, MAP should also be considered in younger patients (35-55 years) with only few adenomas or colorectal cancer. The high frequency of medium and severe dysplasia in the patient's preferential small adenomas suggests accelerated progression from adenoma to carcinoma in MAP, but this observation must be confirmed by further studies.
PURPOSE: Biallelic germ-line mutations in MUTYH have recently been found to predispose for MUTYH-associated polyposis (MAP). Affected patients present with a wide range of clinical phenotypes at the time of diagnosis, but there is little precise information about the natural course of this disease. RESULTS: Fourteen years of colonoscopic surveillance of an MAP patient (compound heterozygous p.Y165C/p.G382D) showed that adenoma development was slow after initial diagnosis of a single colorectal carcinoma at the age of 44, but then the annual number of new adenomas increased substantially in the patient's early fifties. CONCLUSION: This course of the disease, with a strong subsequent acceleration of polyp development, may explain the wide range of polyp numbers counted in newly diagnosed MAP patients as a result of the time of observation. Therefore, MAP should also be considered in younger patients (35-55 years) with only few adenomas or colorectal cancer. The high frequency of medium and severe dysplasia in the patient's preferential small adenomas suggests accelerated progression from adenoma to carcinoma in MAP, but this observation must be confirmed by further studies.
Authors: Gitana Aceto; Maria Cristina Curia; Serena Veschi; Laura De Lellis; Sandra Mammarella; Teresa Catalano; Liborio Stuppia; Giandomenico Palka; Rosa Valanzano; Francesco Tonelli; Vincenzo Casale; Vittoria Stigliano; Francesco Cetta; Pasquale Battista; Renato Mariani-Costantini; Alessandro Cama Journal: Hum Mutat Date: 2005-10 Impact factor: 4.878
Authors: Nada Al-Tassan; Nikolas H Chmiel; Julie Maynard; Nick Fleming; Alison L Livingston; Geraint T Williams; Angela K Hodges; D Rhodri Davies; Sheila S David; Julian R Sampson; Jeremy P Cheadle Journal: Nat Genet Date: 2002-01-30 Impact factor: 38.330
Authors: Marina E Croitoru; Sean P Cleary; Nando Di Nicola; Michael Manno; Teresa Selander; Melyssa Aronson; Mark Redston; Michelle Cotterchio; Julia Knight; Robert Gryfe; Steven Gallinger Journal: J Natl Cancer Inst Date: 2004-11-03 Impact factor: 13.506
Authors: S M Powell; N Zilz; Y Beazer-Barclay; T M Bryan; S R Hamilton; S N Thibodeau; B Vogelstein; K W Kinzler Journal: Nature Date: 1992-09-17 Impact factor: 49.962
Authors: Julian R Sampson; Sunil Dolwani; Sian Jones; Diana Eccles; Anthony Ellis; D Gareth Evans; Ian Frayling; Sheila Jordan; Eamonn R Maher; Tony Mak; Julie Maynard; Francesca Pigatto; Joan Shaw; Jeremy P Cheadle Journal: Lancet Date: 2003-07-05 Impact factor: 79.321
Authors: Lara Lipton; Sarah E Halford; Victoria Johnson; Marco R Novelli; Angela Jones; Carole Cummings; Ella Barclay; Oliver Sieber; Amir Sadat; Marie-Luise Bisgaard; Shirley V Hodgson; Lauri A Aaltonen; Huw J W Thomas; Ian P M Tomlinson Journal: Cancer Res Date: 2003-11-15 Impact factor: 12.701
Authors: Liang Wang; Linnea M Baudhuin; Lisa A Boardman; Kelle J Steenblock; Gloria M Petersen; Kevin C Halling; Amy J French; Ruth A Johnson; Lawrence J Burgart; Kari Rabe; Noralane M Lindor; Stephen N Thibodeau Journal: Gastroenterology Date: 2004-07 Impact factor: 22.682
Authors: Susan M Farrington; Albert Tenesa; Rebecca Barnetson; Alice Wiltshire; James Prendergast; Mary Porteous; Harry Campbell; Malcolm G Dunlop Journal: Am J Hum Genet Date: 2005-05-03 Impact factor: 11.025
Authors: Monika Morak; Barbara Heidenreich; Gisela Keller; Heather Hampel; Andreas Laner; Albert de la Chapelle; Elke Holinski-Feder Journal: Eur J Hum Genet Date: 2014-02-12 Impact factor: 4.246